Further, ALRI demonstrated utility in Stage II and Stage III CRC patients, implying that in Stage I CRC, alterations in albumin and lymphocyte levels might be less pronounced, potentially due to the smaller tumor volume13. This evidence concerns the gene ALB and neoplasm.